Phathom Pharmaceuticals Inc. (PHAT)
NASDAQ · Healthcare
Phathom Pharmaceuticals Inc. Income Statement 2022–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | |
|---|---|---|---|---|
| Revenues | ||||
| Revenue | 175.1M | 55.3M | 682,000 | 0 |
| Gross Profit | 152.5M | 47.3M | 515,000 | 0 |
| Profitability | ||||
| Operating Income | -160.0M | -277.5M | -167.3M | -172.4M |
| EBITDA | — | — | — | — |
| Net Income | -221.2M | -334.3M | -201.6M | -197.7M |
| Per Share Data | ||||
| EPS (diluted) | — | — | — | — |
| Shares Outstanding (dil.) | 73M | 63M | 51M | 39M |
Phathom Pharmaceuticals Inc. Income Statement — FAQ
Phathom Pharmaceuticals Inc. (PHAT) income statement over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see PHAT's income statement history?
The chart and table above show Phathom Pharmaceuticals Inc.'s income statement by year and by quarter, including the growth rate.